Related Experiment Videos
Platelet aggregability, disaggregability and serotonin uptake in migraine
Cephalalgia : an International Journal of Headache
|December 1, 1984
Summary
Platelet aggregation and serotonin uptake show subtle differences in migraine patients compared to controls. These changes, while statistically significant, may not be clinically relevant for migraine diagnosis or treatment.
Area of Science:
- Neuroscience
- Hematology
- Pharmacology
Background:
- Migraine is associated with platelet function disturbances, including serotonin metabolism and aggregation.
- Previous studies suggest alterations in platelet behavior in individuals with migraine.
Purpose of the Study:
- To compare platelet function, specifically serotonin uptake and aggregation, in migraineurs during attacks and headache-free periods versus controls.
- To investigate the kinetic parameters of serotonin uptake and the effect of imipramine inhibition in migraine platelets.
Main Methods:
- Platelet-rich plasma was obtained from migraineurs (during attacks and headache-free) and healthy controls.
- Platelet aggregability was measured.
- Kinetic analysis of serotonin (5-HT) uptake was performed, including determination of Km, Vmax, and imipramine inhibition.
Main Results:
- Platelet aggregability showed a tendency to increase during migraine attacks compared to headache-free periods, and was lowest in controls.
- Serotonin uptake kinetics in migraineurs revealed normal Km, increased Vmax, and reduced imipramine inhibition, irrespective of headache status.
- While statistically significant, the observed differences in platelet function were quantitatively small.
Conclusions:
- Migraineurs exhibit minor alterations in platelet serotonin uptake and aggregation compared to controls.
- The clinical significance of these subtle platelet function changes in migraine requires further investigation.